Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in AIDS

Retrieve available abstracts of 36 articles:
HTML format

Single Articles

    February 2022
  1. HAWKINS C, Kang M, Bhattacharya D, Cloherty G, et al
    Hepatitis B surface antigen and Hepatitis B RNA changes in HIV/HBV Co-infected participants receiving HBV-active antiretroviral therapy for 144 weeks.
    AIDS. 2022 Feb 14. pii: 00002030-900000000-96218.
    PubMed     Abstract available

  2. SHAVER ZM, Anderson M, Bhebhe L, Baruti K, et al
    Decreased HBV vaccine response among HIV positive infants compared to HIV negative infants in Botswana.
    AIDS. 2022 Feb 1. pii: 00002030-900000000-96228.
    PubMed     Abstract available

    January 2022
  3. ISFORDINK CJ, Smit C, Boyd A, de Regt MJA, et al
    Low HCV-viremia prevalence yet continued barriers to direct-acting antiviral treatment in people living with HIV in the Netherlands.
    AIDS. 2022 Jan 6. pii: 00002030-900000000-96245.
    PubMed     Abstract available

    November 2021
  4. JEUDY J, Patel P, George N, Burrowes S, et al
    Assessment of coronary inflammation in antiretroviral treated people living with HIV infection and active HIV/HCV co-infection.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96274.
    PubMed     Abstract available

    October 2021
  5. FURSA O, Mocroft A, Lazarus JV, Amele S, et al
    The hepatitis C cascade of care in HIV/HCV-coinfected individuals in Europe- regional and intra-regional differences.
    AIDS. 2021 Oct 25. pii: 00002030-900000000-96284.
    PubMed     Abstract available

  6. QUINN JR, Goyal A, Ribeiro RM, Massaccesi G, et al
    Antiretroviral therapy for HIV and intrahepatic hepatitis C virus replication.
    AIDS. 2021 Oct 25. pii: 00002030-900000000-96283.
    PubMed     Abstract available

    September 2021
  7. FRANCO S, Horneros J, Soldevila L, Ouchi D, et al
    Single nucleotide polymorphisms in PNPLA3, ADAR-1, and IFIH1 are associated with advanced liver fibrosis in patients co-infected with HIV-1/HCV.
    AIDS. 2021 Sep 2. pii: 00002030-900000000-96321.
    PubMed     Abstract available

    August 2021
  8. MICAN R, Busca Arenzana C, Vasquez J, Daroca G, et al
    Hepatitis B reactivation after tenofovir withdrawal in an HIV-infected patient with history of cured hepatitis B virus infection and poor immunological status.
    AIDS. 2021;35:1707-1708.

    Hepatitis C virus infection and cardiac dysfunction in women.
    AIDS. 2021;35:1689-1690.

    July 2021
    Circulating micro-RNAs as biomarkers of liver fibrosis progression in hepatitis C virus/HIV-1-co-infected patients: a 'miR'-velous opportunity of early diagnosis?
    AIDS. 2021;35:1499-1500.

  11. RAMOS-RINCON JM, Pinargote H, Ramos-Belinchon C, de Mendoza C, et al
    Hepatitis delta in patients hospitalized in Spain (1997-2018).
    AIDS. 2021 Jul 13. pii: 00002030-900000000-96346.
    PubMed     Abstract available

    June 2021
  12. GUARDIGNI V, Toschi A, Badia L, Del Turco ER, et al
    Patients living with HIV and cirrhosis: the risk for hepatocellular carcinoma after direct-acting antivirals for HCV.
    AIDS. 2021 Jun 4. pii: 00002030-900000000-96387.
    PubMed     Abstract available

    May 2021
  13. CORMA-GOMEZ A, Macias J, Tellez F, Morano L, et al
    Kinetics of emergence of liver complications in HCV-infected patients and advanced fibrosis, with and without HIV-coinfection, after SVR.
    AIDS. 2021 May 27. pii: 00002030-900000000-96392.
    PubMed     Abstract available

  14. HAMADY A, Cooke GS, Garvey LJ
    Identification of hepatitis delta superinfection when investigating transaminitis in HIV/HBV coinfection.
    AIDS. 2021 May 10. pii: 00002030-900000000-96410.
    PubMed     Abstract available

  15. CHADWICK D, Forbes G, Lawrence C, Lorrimer S, et al
    Using an electronic health record alert to prompt blood-borne virus testing in primary care.
    AIDS. 2021 May 10. pii: 00002030-900000000-96408.
    PubMed     Abstract available

    April 2021
  16. HUNG R, Patel N, Fox J, Cosgrove C, et al
    Prevalence of HIV/hepatitis B and HIV/hepatitis C coinfection among people of East, South, Central and West African ancestry in the United Kingdom.
    AIDS. 2021 Apr 28. pii: 00002030-900000000-96416.
    PubMed     Abstract available

  17. SHITOLE SG, Lazar JM, Hanna DB, Kim RS, et al
    HIV, HCV and risk of new-onset left ventricular dysfunction: the women's interagency HIV study.
    AIDS. 2021 Apr 15. pii: 00002030-900000000-96421.
    PubMed     Abstract available

  18. PREININGER L, Kahal DA, Szabo S
    Hepatitis B vaccination response and safety in people living with HIV/AIDS receiving HepB-CpG series.
    AIDS. 2021;35:845-846.

    March 2021
  19. FRANCO S, Buccione D, Tural C, Martinez MA, et al
    Circulating microRNA signatures that predict liver fibrosis progression in patients with HIV-1/HCV co-infections.
    AIDS. 2021 Mar 31. pii: 00002030-900000000-96441.
    PubMed     Abstract available

  20. FRENCH AL, Grennan D, Daubert E, Seaberg EC, et al
    Decreases in markers of monocyte/macrophage activation after hepatitis C eradication in HIV/HCV co-infected women.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96468.
    PubMed     Abstract available

    February 2021
  21. FALADE-NWULIA O, Seaberg EC, Snider AE, Rinaldo CR, et al
    Outcomes of acute hepatitis B virus (HBV) in HIV infection with and without HBV-active antiretroviral therapy.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96487.
    PubMed     Abstract available

    November 2020

  22. Recently acquired and early chronic hepatitis C in MSM: Recommendations from the European treatment network for HIV, hepatitis and global infectious diseases Consensus panel: Erratum.
    AIDS. 2020;34:2161-2163.

    October 2020
  23. DES JARLAIS DC, Duong Thi H, Khuat Thi Hai O, Feelemyer JP, et al
    Ending an HIV epidemic among persons who inject drugs (PWID) in a middle-income country: extremely low HIV incidence among PWID in Hai Phong, Viet Nam.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002712.
    PubMed     Abstract available

  24. SANTOS ME, Protopopescu C, Ribero RA, Benzaken AS, et al
    Population attributable fractions of mortality in people living with HIV: roles of delayed antiretroviral therapy, hepatitis coinfections and social factors.
    AIDS. 2020;34:1843-1854.
    PubMed     Abstract available

    September 2020
  25. CACHAY ER, Torriani FJ, Hill L, Jain S, et al
    The role of barriers to care on the propensity for hepatitis C virus nonreferral among people living with HIV.
    AIDS. 2020;34:1681-1683.
    PubMed     Abstract available

  26. MOLINA-ITURRITZA E, San-Jose-Muniz I, Ganchegui-Aguirre M, Balerdi-Sarasola L, et al
    Coronavirus disease 2019 in patients with HIV in the province of Araba, Basque Country, Spain.
    AIDS. 2020;34:1696-1697.

    August 2020
  27. DEZANET LNC, Maylin S, Gabassi A, Rougier H, et al
    Correlation of serum hepatitis B core-related antigen with HBV total intrahepatic DNA and ccc-DNA viral load in HIV-hepatitis B coinfection.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002659.
    PubMed     Abstract available

  28. MERCHANTE N, Rodriguez-Fernandez M, Figueruela B, Rodriguez-Arrondo F, et al
    Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients.
    AIDS. 2020;34:1497-1507.
    PubMed     Abstract available

  29. MOCROFT A, Ryom L, Oprea C, Li Q, et al
    Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive persons.
    AIDS. 2020;34:1485-1495.
    PubMed     Abstract available

  30. GIRON LB, Azzoni L, Yin X, Lynn KM, et al
    Hepatitis C virus modulates IgG glycosylation in HIV co-infected antiretroviral therapy suppressed individuals.
    AIDS. 2020;34:1461-1466.
    PubMed     Abstract available

    July 2020
  31. SANTOS ME, Protopopescu C, Ribeiro RA, Benzaken AS, et al
    Population attributable fractions of mortality in people living with HIV: roles of delayed ART, hepatitis coinfections and social factors.
    AIDS. 2020 Jul 23. doi: 10.1097/QAD.0000000000002621.
    PubMed     Abstract available

  32. CACHAY ER, Torriani FJ, Hill L, Jain S, et al
    The role of barriers to care on the propensity for HCV non-referral among people living with HIV.
    AIDS. 2020 Jul 21. doi: 10.1097/QAD.0000000000002610.
    PubMed     Abstract available

    Recently acquired and early chronic hepatitis C in men having sex with men (MSM): Recommendations from the NEAT-ID consensus panel.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002622.
    PubMed     Abstract available

  34. HOSSEINI-HOOSHYAR S, Martinello M, Yee J, Read P, et al
    Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV.
    AIDS. 2020;34:1347-1358.
    PubMed     Abstract available

    May 2020
  35. COSTINIUK CT, Jenabian MA
    Reply to: Benefits of cannabis use for metabolic disorders and survival in people living with HIV with or without hepatitis C.
    AIDS. 2020;34:955-956.

  36. SANTOS ME, Protopopescu C, Zucman D, Marcellin F, et al
    Benefits of cannabis use for metabolic disorders and survival in people living with HIV with or without hepatitis C co-infection.
    AIDS. 2020;34:953-954.

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.